Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
Mónica Imbernón(Inserm), Vincent Prévot(Centre Hospitalier Universitaire de Lille), Serge Luquet(Centre National de la Recherche Scientifique), Hans Christian Cederberg Helms(University of Copenhagen), Daniela Herrera Moro Chao(Université Paris Cité), Chiara Saponaro(University of Siena), Sowmyalakshmí Rasika(Inserm), Daniela Fernandois(Inserm), R Denis(Centre National de la Recherche Scientifique), Birger Brodin(University of Copenhagen), Manon Duquenne(Inserm), Frank W. Pfrieger(Université de Strasbourg), Eleonora Deligia(Inserm), Bart Staels(National Institutes of Health), Caroline Bonner(Inserm), François Pattou(Inserm)
Cited by 118
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901